These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26049666)

  • 21. Lipid mediators of liver injury in nonalcoholic fatty liver disease.
    Liangpunsakul S; Chalasani N
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G75-G81. PubMed ID: 30383414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease.
    Leclercq I
    Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MSDC-0602K, a metabolic modulator directed at the core pathology of non-alcoholic steatohepatitis.
    Colca JR; McDonald WG; Adams WJ
    Expert Opin Investig Drugs; 2018 Jul; 27(7):631-636. PubMed ID: 29950116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis.
    Su Q; Kumar V; Sud N; Mahato RI
    Adv Drug Deliv Rev; 2018 Apr; 129():54-63. PubMed ID: 29391222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease.
    Masarone M; Rosato V; Dallio M; Gravina AG; Aglitti A; Loguercio C; Federico A; Persico M
    Oxid Med Cell Longev; 2018; 2018():9547613. PubMed ID: 29991976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.
    Cobbina E; Akhlaghi F
    Drug Metab Rev; 2017 May; 49(2):197-211. PubMed ID: 28303724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
    Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
    Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steatosis and NASH in type 2 diabetes.
    Hu M; Phan F; Bourron O; Ferré P; Foufelle F
    Biochimie; 2017 Dec; 143():37-41. PubMed ID: 29097281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.
    Lau JK; Zhang X; Yu J
    J Pathol; 2017 Jan; 241(1):36-44. PubMed ID: 27757953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.
    Meex RCR; Watt MJ
    Nat Rev Endocrinol; 2017 Sep; 13(9):509-520. PubMed ID: 28621339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.
    Perla FM; Prelati M; Lavorato M; Visicchio D; Anania C
    Children (Basel); 2017 Jun; 4(6):. PubMed ID: 28587303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
    Buzzetti E; Pinzani M; Tsochatzis EA
    Metabolism; 2016 Aug; 65(8):1038-48. PubMed ID: 26823198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?
    García-Ruiz C; Baulies A; Mari M; García-Rovés PM; Fernandez-Checa JC
    Free Radic Res; 2013 Nov; 47(11):854-68. PubMed ID: 23915028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational Hypothesis: How Intra-Hepatic Functional Heterogeneity May Influence the Cascading Progression of Free Fatty Acid-Induced Non-Alcoholic Fatty Liver Disease (NAFLD).
    Holzhütter HG; Berndt N
    Cells; 2021 Mar; 10(3):. PubMed ID: 33808045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
    Byrne CD
    Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease.
    Ashraf NU; Sheikh TA
    Free Radic Res; 2015; 49(12):1405-18. PubMed ID: 26223319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease].
    Kim MY
    Korean J Gastroenterol; 2017 Jun; 69(6):341-347. PubMed ID: 28637102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
    Geng Y; Faber KN; de Meijer VE; Blokzijl H; Moshage H
    Hepatol Int; 2021 Feb; 15(1):21-35. PubMed ID: 33548031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of nonalcoholic steatohepatitis.
    Liu W; Baker RD; Bhatia T; Zhu L; Baker SS
    Cell Mol Life Sci; 2016 May; 73(10):1969-87. PubMed ID: 26894897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.